Tuesday 22 July 2014
Hikma Pharmaceuticals

Hikma H1 revenue up 20pc to $638m

Hikma Pharmaceuticals, a top multinational pharmaceutical group, has reported revenue of $638.3 million in the first half of 2013, reflecting a 19.9 per cent increase over the same period last year. The Group is expected to delive


Hikma Pharma to spend $300m on expansion

London-listed Hikma Pharmaceuticals plans to spend nearly $300 million on acquisitions and expansion initiatives in 2012 amid strong growth prospects in the Middle East and North Africa, its chief financial officer said. "In terms of acqui


Hikma Pharma H1 sales up 10pc

Jordanian pharma company Hikma saw its first-half revenue surge 10.4 per cent despite problems in other North African and Middle East markets due to a strong sales in Algeria, Sudan and Iraq. Hikma, which sells both generic and b


Hikma sees revenue growth

Jordanian drugmaker Hikma Pharmaceuticals said it expected first-half revenue to grow around 40 per cent. Hikma also said in a trading update, ahead of the release of results for the first half of 2007 on September 5, it was confident of d

 1 2 3 4 5 >  Last ›

calendarCalendar of Events


Buy high quality China wholesale Health & Beauty , Electronics, Sports & Outdoors , Computers, Video Games, Toys & Hobbies Cell Phones, Automobiles and other wholesale products directly from reliable Chinese wholesalers or Factories on DHgate.com